| Trial ID: | L1769 |
| Source ID: | NCT00813020
|
| Associated Drug: |
Semaglutide
|
| Title: |
A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male Subjects
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: semaglutide|DRUG: semaglutide|DRUG: semaglutide
|
| Outcome Measures: |
Primary: AUC0-8 (NN9535), the area under the plasma NN9535 plasma-concentration-time curve in the interval 0-8 after investigational medicinal product administration, a 28 day time period | Secondary: Cmax of the plasma NN9535 curve, a 28 day time period
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
44
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-01
|
| Completion Date: |
2009-04
|
| Results First Posted: |
|
| Last Update Posted: |
2015-02-23
|
| Locations: |
Berlin, 14050, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00813020
|
